V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20059142 | 20086749 | 1.78 | 66 | 03 | 2018-04-12 | 2018-04-24 | Docetaxel 75mg/m2 (21 day) | N | null | HYDROXYCARBAMIDE | 100429515 |
| 20059198 | 20086750 | 1.73 | 55.2 | 03 | 2019-04-05 | 2019-04-06 | Capecitabine + Streptozocin | 02 | N | NOT MATCHED | 100561399 |
| 20059260 | 20086752 | 1.75 | 72.8 | null | 2018-01-26 | 2018-02-22 | EOF | N | Y | NAB-PACLITAXEL | 101748412 |
| 20059271 | 20086753 | 1.8 | 51.7 | null | 2016-08-13 | 2016-08-20 | SCOPE 2 TRIAL | 02 | N | GO2 TRIAL | 100261787 |
| 20059294 | 20086754 | 1.77 | 69.6 | null | 2019-05-04 | 2019-05-04 | Irinotecan | 02 | N | GEMCITABINE + PACLITAXEL | 100947032 |
| 20059307 | 20086755 | 1.78 | 75.5 | 03 | 2020-03-01 | 2020-03-15 | CAP + RT | N | N | BENDAMUSTINE + RITUXIMAB | 101674366 |
| 20059322 | 20086756 | 1.74 | 67.3 | 03 | 2018-06-16 | 2018-06-16 | IPILIMUMAB + NIVOLUMAB | 02 | Y | LETROZOLE + PALBOCICLIB | 101565273 |
| 20059331 | 20086757 | 1.45 | 101 | Palliative (P) | 2019-12-20 | 2019-12-20 | Bortezomib + Cyclophos + Dex | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100414413 |
| 20059335 | 20086758 | 1.61 | 69.4 | 03 | 2018-08-16 | 2018-08-21 | OXALIPLATIN | 02 | N | RITUXIMAB | 101574350 |
| 20059528 | 20086759 | 1.65 | 105 | 03 | 2018-05-15 | 2018-05-24 | BORTEZOMIB + THALIDOMIDE | 02 | Y | NOT MATCHED | 101734111 |
| 20059587 | 20086762 | 1.77 | 51 | 03 | 2019-09-16 | 2019-09-25 | Capecitabine + Carboplatin + RT | 02 | N | DOCETAXEL | 100711247 |
| 20059590 | 20086763 | 1.71 | 69.9 | Palliative (P) | 2017-03-02 | 2017-03-12 | CVP R | 99 | N | RITUXIMAB | 101456514 |
| 20059646 | 20086764 | 0 | 0 | null | 2017-06-21 | 2017-07-10 | null | N | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 100357786 |
| 20059654 | 20086765 | 1.65 | 115 | Adjuvant (A) | 2017-03-22 | 2017-04-10 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 100158954 |
| 20059690 | 20086766 | 1.77 | 73 | null | 2021-05-16 | 2021-05-19 | FEC 60 or 75 | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100832793 |
| 20059694 | 20086768 | 1.78 | 83 | Palliative (P) | 2019-01-05 | 2019-01-06 | CHOP R - 21 days | 2 | N | CVP R | 101830387 |
| 20059704 | 20086769 | 1.84 | 83.75 | Palliative (P) | 2019-04-30 | 2019-05-05 | GemCarbo Days 1+8 | null | N | CISPLATIN + TEYSUNO | 101383789 |
| 20059739 | 20086770 | 1.63 | 62 | 03 | 2018-03-30 | 2018-04-04 | Panitumumab | N | N | DOXORUBICIN | 101252713 |
| 20059746 | 20086771 | null | 68 | 03 | null | 2019-10-31 | BEVACIZUMAB + CARBO | N | N | IRINOTECAN | 100684426 |
| 20059788 | 20086773 | 1.67 | 85.3 | Curative (C) | 2017-12-03 | 2017-12-21 | ARISTOTLE TRIAL | 02 | N | CISPLATIN + FLUOROURACIL + RT | 100195609 |
| 20059818 | 20086774 | 1.5 | 58.5 | 03 | 2020-11-28 | 2020-12-11 | Gemcitabine+Paclitaxel (Neo-tAnGo) | 02 | N | PACLITAXEL | 101771170 |
| 20059819 | 20086775 | 1.8 | 80 | Palliative (P) | 2020-01-06 | 2020-01-27 | PACLITAXEL ALBUMIN (ABRAXANE) | 2 | Y | CLADRIBINE | 101516463 |
| 20059846 | 20086776 | 1.8 | 67.4 | Palliative (P) | 2017-03-20 | 2017-03-25 | CARBOPLATIN + GEMCITABINE | N | N | ECARBOX | 101777712 |
| 20059978 | 20086778 | 1.51 | 86.6 | null | 2017-07-22 | 2017-08-02 | EEF or EOF | 02 | Y | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 100126921 |
| 20059990 | 20086779 | 1.6 | 101.8 | Adjuvant (A) | 2018-03-10 | 2020-08-09 | INCA TRIAL | 01 | N | IRINOTECAN | 101495976 |
| 20060043 | 20086780 | 1.52 | 74.4 | 03 | 2019-01-11 | 2019-01-27 | OXALIPLATIN + MDG + PANITUMUMAB | Y | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 101354502 |
| 20060056 | 20086781 | 1.78 | 80.7 | Palliative (P) | 2017-01-19 | 2017-01-21 | EOF | 02 | N | IBRUTINIB | 100880100 |
| 20060087 | 20086782 | 1.6 | 95.35 | null | 2015-10-23 | 2015-10-28 | Fluorouracil + Folinic + RT Bossett | 02 | N | OXALIPLATIN | 100135101 |
| 20060122 | 20086783 | 1.78 | 63.2 | null | 2019-10-10 | 2019-10-28 | EEF or EOF | 02 | N | PLATO TRIAL | 101418693 |
| 20060131 | 20086784 | 1.81 | 53.6 | Adjuvant (A) | 2017-03-26 | 2017-04-03 | Fluorouracil + Folinic + RT Bossett | N | N | CAPECITABINE + STREPTOZOCIN | 101645497 |
| 20060155 | 20086785 | 1.68 | 58 | Adjuvant (A) | 2017-02-15 | 2017-02-21 | PEMBROLIZUMAB | N | N | FOXTROT TRIAL | 101403267 |
| 20060170 | 20086786 | 1.66 | 86.9 | Palliative (P) | 2018-02-12 | 2018-03-13 | Docetaxel 75mg/m2 (21 day) | N | N | PLATO TRIAL | 101475262 |
| 20060181 | 20086787 | 0 | 0 | Neo-adjuvant (N) | 2016-05-07 | 2016-06-05 | Cabazitaxel | 02 | N | EVEROLIMUS | 100710143 |
| 20060201 | 20086788 | 1.75 | 71 | 03 | 2020-06-10 | 2020-06-10 | Palbociclib | 02 | N | ACELARATE TRIAL | 100899964 |
| 20060232 | 20086789 | 1.56 | 93.3 | 03 | 2016-12-09 | 2016-12-25 | CHOP R | null | N | CAP + RT | 100376893 |
| 20060295 | 20086790 | 1.57 | 70 | Palliative (P) | 2017-11-28 | 2017-12-05 | Carboplatin+Fluorouracil 4 or 5 day | null | N | OXALIPLATIN + MDG + PANITUMUMAB | 100322547 |
| 20060367 | 20086792 | 1.74 | 91.5 | Neo-adjuvant (N) | 2019-01-08 | 2019-01-19 | null | 02 | N | EVEROLIMUS | 100168449 |
| 20060391 | 20086793 | 1.71 | 50.3 | Palliative (P) | 2019-12-18 | 2019-12-18 | SCOPE 2 TRIAL | N | N | CAPECITABINE + CISPLATIN + STREPTOZOCIN | 101710700 |
| 20060394 | 20086795 | 1.74 | 65.8 | Palliative (P) | null | 2018-06-13 | CAPECITABINE + OXALIPLATIN + RT | 01 | N | PACLITAXEL | 101416467 |
| 20060449 | 20086796 | 1.87 | 66 | Palliative (P) | 2017-06-09 | 2017-06-26 | PEMBROLIZUMAB | 02 | Y | MELPHALAN | 100132558 |
| 20060457 | 20086797 | 1.63 | 67.1 | 03 | 2019-04-15 | 2019-04-19 | IBRUTINIB | 01 | N | ECARBOX | 101549686 |
| 20060467 | 20086798 | 1.7 | 46.9 | 03 | 2017-05-26 | 2017-06-17 | BCG Intravesical | 02 | N | TIPIRACIL + TRIFLURIDINE | 100491114 |
| 20060486 | 20086799 | 1.68 | 76.6 | Palliative (P) | 2019-09-09 | 2019-09-17 | Capecitabine + Streptozocin | 02 | N | CARBO + FLUOROURACIL | 100127080 |
| 20060603 | 20086800 | 1.54 | 69.9 | Palliative (P) | 2019-07-04 | 2019-07-14 | ChIVPP/EVA | 02 | N | NIVOLUMAB | 101801437 |
| 20060637 | 20086801 | 1.67 | 107.5 | Palliative (P) | 2020-02-02 | 2020-02-02 | Bortezomib + Cyclophos + Dex | 02 | N | MIC | 100836935 |
| 20060655 | 20086802 | 1.65 | 66.2 | null | 2019-01-07 | 2019-01-15 | CNS ATRT Doxorubicin + GCSF | 02 | N | EOF | 100065904 |
| 20060675 | 20086803 | 1.55 | 91.8 | Palliative (P) | 2018-02-02 | 2018-02-03 | Bevacizumab + FLUOROURACIL + IRINOTECAN | 01 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 100392594 |
| 20060677 | 20086804 | 1.61 | 92 | Palliative (P) | 2019-10-18 | 2019-10-29 | null | 02 | N | CARBOPLATIN + FLUOROURACIL | 101834878 |
| 20060751 | 20086805 | 1.8 | null | Adjuvant (A) | 2017-06-13 | 2017-07-16 | Irinotecan | 02 | N | CHOP R | 101176581 |
| 20060754 | 20086806 | 1.75 | 64.9 | 03 | 2018-10-22 | 2018-12-01 | Raltitrexed | 01 | N | PACLITAXEL | 101781127 |